Abstract:e13689 Background: More than seventy-three thousand new breast cancer cases are expected in Brazil for the year 2023, representing the most common malignancy in this country. Delaying time to treatment initiation has been associated with increased risk of worse outcomes. The Brazilian government developed several initiatives to accelerate the access of cancer patients to treatment in an adequate time-bound. One of these is a federal law defining that oncological treatment should begin within 60 days of pathological diagnosis. Methods: This retrospective study analyzed data of newly diagnosed breast cancer patients in 2022–2023 in Hospital de Clinicas de Porto Alegre (HCPA), a public hospital in Porto Alegre, Brazil. The primary objective was to build a predictive model of risk factors that could delay the time to first treatment beyond 60 days from diagnosis. The present analysis describes the socio-demographic characteristics of these patients and explores their impact on the time to oncologic treatment initiation. This project was approved by the Ethics and Research Committee (registration CAAE 71160423.7.0000.5327). Results: 184 patients who started their oncological treatment between 2022-2023 in HCPA were enrolled; 32 patients (17,3%) had their first treatment after 60 days from the diagnosis while 152 (82,7%) were treated before 60 days; 106 (57,3%) patients had studied up to elementary school and 32 (17,3%) were non-white; 53 patients (23%) had been submitted to biopsy outside HCPA. Patients who started their first treatment before 60 days had a mean of 38 days from diagnosis to first treatment while those treated after 60 days had a mean of 75,6 days. To evaluate how socio-demographic factors impacted the time to treatment initiation, a multivariate Poisson log-linear model adjusted for race, city of residence, stage of the disease, and type of first treatment considered different variables. Higher educational level had a statistically significant effect, with a rate ratio (RR) of 0.32 (95% CI 0.157 - 0.650, p < 0.05). We also found that performing biopsy in our institution instead of doing it elsewhere had a statistically significant impact on the time to first treatment, with an RR of 0.512 (95% CI 0.274 - 0.957, p = 0.036). Ethnicity was not related to delay of treatment (p-value=0.125). Conclusions: This study identified that socio-demographic factors are crucial to guarantee the appropriate time to start treatment for breast cancer patients in a middle-income country. Higher educational level had a positive impact on time-to-treatment initiation, as well as to perform biopsy in the same institution patients were treated. In this first analysis, ethnicity, clinical staging, and type of first treatment did not meet the statistical criteria to be considered relevant and the accrual of more patients is needed for further conclusions.

Clinicoepidemiological Profile And Time To Treatment Initiation Of Oral And Oropharyngeal Cancer Patients In Brazil.

Clinical And Demographic Analysis Of Oral Squamous Cell Carcinoma In A Brazilian Population.

Prevalence Of Oral Cancer In A Brazilian Population: A Cross-Sectional Study Of 38 Years.

Analysis of the clinical, epidemiological and mortality profile of Gastric Cancer in Brazil

Breast cancer treatment access disparities: A retrospective cohort study of breast cancer in patients treated at a high-complex cancer center in southern Brazil.

Incidence and mortality rates of lip, oral cavity, and pharynx cancers in Brazil: time-trend and age-period-cohort analysis from the last 30 years, Global Burden of Disease Study

Prevalence of oral lesions in elderly patients on oral cancer prevention campaigns in Parana state Brazil 1989-2013.

Demographic And Clinicopathological Characterization Of Incipient Oral Squamous Cell Carcinoma: A South-American Study.

Can predictive factors determine the time to treatment initiation for oral and oropharyngeal cancer? A classification and regression tree analysis

Knowledge, Attitudes, Practices, and Perceptions of Brazilian Dentists About Oral Cancer

Evaluation Of The Period Elapsed For Surgical Treatment Of Diagnosed Cases Of Oral Cancer.

Oral Benign Neoplasms: A Retrospective Study In A Brazilian Population.

Specialized Care In Oral Medicine In The Prognosis Of Patients Referred To An Oncological Center: Retrospective Cohort.

Evaluation Of Lip Cancer Records And Oral Health Services In Brazil.

Evaluation Of Hospitalization In Oral And Pharyngeal Cancer In Brazil Between 2008 And 2017.

Real world data on cervical cancer treatment patterns, healthcare access and resource utilization in the Brazilian public healthcare system

Oral Cavity Cancer In Adults In The State Of Santa Catarina Between 2009 And 2018: An Ecological Study.

Prospective Cohort Study Identifies Medical Predictors of Treatment-Related Oral Toxicities in Oral and Oropharyngeal Cancer Patients

Barriers to early diagnosis and management of oral cancer in Latin America and the Caribbean

Lip And Oral Cancer Incidence And Tobacco Control Policies In Mercosur.

Performance And Outcomes Of Oral Cancer Screening In The Latin American Region: A Systematic Review.